Skip to main content
. 2018 Dec 28;9(102):37753–37765. doi: 10.18632/oncotarget.26514

Figure 6. Inhibition of CK2/CDK4 mediated signaling by ON108110.

Figure 6

(A) CEM and (B) Granta-519 cells were treated with increasing concentrations of ON 108110 for 24 hours. Whole cell extracts were subjected to western blot analysis using antibodies directed against the indicated proteins. GAPDH is shown as a loading control.